Home / Innovation
Innovation · Scope Futures
Scope Futures: where our next growth comes from
Fearless innovation with one purpose: a better quality of life for patients. Scope Futures brings together our own research, new ideas and the right external partners to build the next generation of eye care.

Scope Futures
One pipeline, three ways in
Our future portfolio is built on three connected teams. Ideation sits upstream, feeding new projects to R&D, while Business Development brings in proven products and technologies from outside.
01
Ideation & discovery
Turning new ideas and emerging science into real projects, ready to hand to R&D.
02
Research & development
Developing our own products, from formulation and testing through to clinical validation.
03
Business partnerships
Bringing in ready-to-go products, technologies and companies that fit where we want to grow.
Our approach
Patient first, science second, product third
Every product starts with a real patient need. We build the evidence before any formulation moves toward production.
01
Patient need first
We start with the symptoms and conditions patients and professionals describe to us, not with a formulation looking for a use.
02
Science second
We build the evidence base, testing and clinical rationale before any formulation moves toward production.
03
Product third
A product only reaches market once the need and the science behind it are established, in that order.
Practice technology
Beyond our brands: tools for dry eye practices
Optase MX2 brings affordable meibography to existing equipment, and Optase Connect gives practices one place to manage and grow their dry eye patients.


Sustainable by design
Designing waste out of dry eye care
Sustainability is built into our products, not added at the end. The COMOD multi-dose device behind HYLO FORTE dispenses a precise drop, lasts six months after opening and replaces over 150 single-dose vials.
Compared with single-dose units, it produces 88% less greenhouse gas emissions and 87% less plastic waste for the same number of doses.
Format comparison by the Centre for Sustainable Healthcare.
